ArticleRadiation oncology (London, England)2021
Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Catherine R Hanna et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.